Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Best Long Term Low Volatility Stocks to Invest In

Page 1 of 14

In this article, we will look at the 15 Best Long Term Low Volatility Stocks to Invest In.

On January 26, Sherry Paul, Morgan Stanley senior portfolio manager, appeared on CNBC’s ‘Closing Bell’ to talk about the state of equity markets and whether more volatility is expected ahead.

According to her, one of the most important things that came out of Davos was going from the phrase globalization to the “new world order”, in which the former felt more like a conscious uncoupling, while the latter has a much harsher tone to it. This translates to the fact that the urgency around reimagining supply chains, partnerships, and the advancement of AI and automation manufacturing in the United States, along with the dollar that is now lower, becomes even higher.

READ ALSO: 10 Best Undervalued Stocks to Buy Under $10 and 10 Best Strong Buy Stocks to Invest In Under $5.

Paul added that this means there is increased volatility ahead, especially as these trends unfold further. However, she also stated that it is important to remember volatility as a part of investing, and that doesn’t necessarily mean that something bad is taking place. According to her, volatility means that something more emergent is happening, and the emergence is moving away from the Mag 7 into what she calls the “magnificent thematics”. If one follows these thematics of the new world order of AI, automation, longevity, innovation, and a couple of others, one can start trailing down into the different sector weightings that people should not be overweighting in, and not necessarily moving into cash.

With these trends in view, let’s look at the best long term low volatility stocks to invest in.

Our Methodology

We sifted through financial media reports and ETFs tracking blue chip and high quality stocks to find the best long term stocks with stable fundamentals and a beta below 1. We then chose the top 15 with the highest number of hedge fund holders, as of Q3 2025. We sourced the hedge fund sentiment data from Insider Monkey’s database. The list is sorted in ascending order of hedge fund holders.

Note: All data was recorded on January 30.

​Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).

15 Best Long Term Low Volatility Stocks to Invest In

15. AstraZeneca PLC (NASDAQ:AZN)

Number of Hedge Fund Holders: 54

AstraZeneca PLC (NASDAQ:AZN) is one of the best long term low volatility stocks to invest in. AstraZeneca PLC (NASDAQ:AZN) announced on January 30 that it is bolstering its weight management portfolio through a new strategic collaboration agreement with CSPC Pharmaceuticals for the advancement of several next-generation therapies for obesity and type 2 diabetes across eight programmes.

The agreement entails the initial progress of four programmes by the companies, leveraging CSPC’s advanced AI-driven peptide drug discovery platform and their proprietary LiquidGel once-monthly dosing platform technology. AstraZeneca PLC (NASDAQ:AZN) reported that it would receive exclusive global rights outside of China to CSPC’s once-monthly injectable weight management portfolio, which includes one clinical-ready asset, SYH2082, a long-acting GLP1R/GIPR agonist progressing into Phase I, and three preclinical programmes with differing mechanisms designed to offer extended therapeutic benefits for people living with obesity and weight-related conditions.

Management further stated that the collaboration complements the company’s existing weight management portfolio, which encompasses an expanding pipeline of next-generation treatments addressing the complexities of obesity and weight-related complications, pursuing multiple modalities and pathways to specialize treatment based on individual needs. This includes elecoglipron (formerly AZD5004), a small molecule oral GLP1RA, AZD9550, a weekly injectable dual GLP-1/glucagon receptor agonist, and AZD6234, a weekly injectable selective amylin receptor agonist (SARA), along with several preclinical assets.

AstraZeneca PLC (NASDAQ:AZN) is a biopharmaceutical company that explores, develops, manufactures, and commercializes prescription medicines. It supplies its products and services to specialty and primary care physicians. AstraZeneca PLC (NASDAQ:AZN) distributes its products and services through local representative offices and distributors.

14. International Business Machines Corporation (NYSE:IBM)

Number of Hedge Fund Holders: 66

International Business Machines Corporation (NYSE:IBM) is one of the best long term low volatility stocks to invest in. Argus lifted the price target on International Business Machines Corporation (NYSE:IBM) to $360 from $340 on January 30, reaffirming a Buy rating on the stock and citing its better-than-anticipated Q4, led by GenAI and hybrid cloud momentum, along with the z17 mainframe. The firm also noted the company’s acquisition of HashiCorp, stating that it brings improved infrastructure and security automation to International Business Machines Corporation’s (NYSE:IBM) hybrid cloud and AI solutions.

International Business Machines Corporation (NYSE:IBM) also received a rating update from RBC Capital on January 29, which lifted the price target on the stock to $361 from $350 and maintained an Outperform rating. The firm told investors that the company delivered a solid end to 2025, delivering a balance of stability and execution in the form of free cash flow outperformance with exposure to secular themes. It added that the strength of the z17 refresh cycle, along with upside from software with a particularly strong data segment, drove revenue upside.

International Business Machines Corporation (NYSE:IBM) is an IT company that provides integrated solutions leveraging information technology and the knowledge of business processes. Its operations are divided into the following segments: Software, Consulting, Infrastructure, Financing, and Other.

Page 1 of 14

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!